Eighteen patients had previously been treated for non-functioning pituitary adenomas (NFPA), 2 patients for GH-producing adenoma, 4 patients for ACTH-producing adenoma, 6 for prolactinoma, and 8 patients for other diseases in the area. The gene discussed is GH1; the disease is pituitary gland adenoma.